Read the Full Article by SonoVascular
SonoVascular, Inc., a clinical stage medical device company focused on bringing to market its SonoThrombectomy™ System, a safer and more effective treatment of venous thromboembolism (VTE), was awarded the Angel Capital Association’s 2025 Luis Villalobos Award in the Life Science category at the Summit of Angel Investing conference in Denver, CO.
Abby Phillips, WIN’s Director, said, “SonoVascular exemplifies what’s possible when world-class research, an exceptional team, and mission-driven investors come together. Their groundbreaking technology and rapid journey from the lab to the clinic are a testament to both the strength of NC State’s entrepreneurial ecosystem and SonoVascular’s ability to execute with precision and purpose. We’re proud to have supported the company from its earliest stages and to continue championing its progress—now recognized with the prestigious 2025 ACA Luis Villalobos Award in Life Sciences.”
- Categories:
